ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 663285 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 663285; 2) Community: the network communities that were significantly associated with the response to NSC 663285; 3) Molecule: the relationships between components within communities and NSC 663285; 4) MDR: the compounds that were significantly associated with the NSC 663285.

NSC Compound Enrichment Correlation
NSC 736157 Null 0.0220039422291536 -0.11573642
NSC 740 Methotrexate 0.0220039422291536 0.36843183
NSC 753769 Null 0.0220039422291536 -0.10975708
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0220039422291536 0.23947201
NSC 10037 Null 0.0220039422291538 0.25665129
NSC 139105 Soluble Baker's Antifol 0.0220039422291538 0.33906223
NSC 176098 Phosphonium, methyl[2-methyl-2-(4-methylphenyl)propyl]diphenyl-, iodide 0.0220039422291538 0.34604534
NSC 313985 Gold(1+), bis(trimethylphosphine)-, chloride 0.0220039422291538 0.49780039
NSC 361127 DESTRUXIN E 0.0220039422291538 0.46330097
NSC 361887 1H-Purine-2,6-dione, 8-[3-(dimethylamino)propoxy]-3,7- dihydro-1,3,7-trimethyl-, mixt. with 1,7-dihydro-6H- purine-6-thione 0.0220039422291538 0.28905581
Total:114  Current:55    [First] [Prev] [Next] [Last]